US Edition30% Longer Life: Cancer Drug Combo Flips the Aging Switch
5 Articles
5 Articles
A new study has shown that a "cocktail" of anti-cancer drugs approved in the US and Europe - trametinib and rapamycin - is 30 percent...
30% Longer Life: Cancer Drug Combo Flips the Aging Switch
A potent drug combo extends mouse lifespan by 30% and boosts health in old age by targeting aging pathways in a unique, synergistic way, raising hopes for future human trials. Mice lived about 30% longer when treated with a combination of Rapamycin and Trametinib, significantly more than either drug alone. The therapy reduced chronic inflammation [...]
Trapetinib and rapamycin could be used as anti-aging therapies.
A research team led by scientists from the Max Planck Institute in Germany tested a combination of two drugs used to treat cancer on mice. They found that the combination therapy extended the rodents' lives by about 30 percent.
One is an immunosuppressant, the other is a drug that is mainly used against skin cancer. Each of them has a significant life-renewal effect in mice, but in combination they break all records: up to 30 percent add the means of the life span in the experiment. This may help to learn how people become healthier and older. What is the secret of a long life? Live up to 20 % longer once – once up to 10 % The two drugs are called rapamycin and trameti…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
